![]() |
市场调查报告书
商品编码
1295309
医用涂料市场 - 2023-2028 年预测Medical Coating Market - Forecasts from 2023 to 2028 |
医疗设备、植入物和小工具需要涂上材料和涂层,以提高功能和安全性。 传染病的流行、微创手术技术的扩展以及对医疗设备的强劲需求推动了市场增长。 此外,对定制多功能涂料不断增长的需求预计将显着扩大市场。 此外,持续的研究和开发提供了新的、独特的涂层选择。 此外,市场进入者的产品创新和战略行动正在为扩展到新的应用领域创造大量机会。
然而,预计限制该市场增长的因素是原材料价格上涨和涂层失效风险。 使用具有亲水/疏水涂层的医疗器械存在涂层缺陷的风险,这是市场增长的主要挑战之一。 此外,其他重要因素,例如涂层类型导致的生物相容性有限、缺乏标准化方法、涂层失效的可能性以及涂层的耐久性,也阻碍了市场的增长。
感染率增加与住院时间延长有关。 常见的医院感染是由导尿管、中心静脉导管和机械呼吸机等医疗器械引起的。 由于医疗器械与人体接触,因此成为医院获得性感染传播的媒介。 因此,出于减少医院感染的需要,医疗器械上的抗菌涂层越来越受欢迎。 这似乎是在不影响患者护理的情况下加强医院环境感染控制的最有效方法。 随着医院获得性感染的增加,抗菌涂层的使用正在扩大。 例如,根据美国疾病控制与预防中心的数据,医疗保健相关感染每年导致超过 98,000 人死亡,并感染约 170 万住院患者。 另外,根据重症监护感染率扩展调查,ICU内感染患者的比例高达51%。
此外,慢性病的流行正在推动各种医疗程序的使用。 这增加了对医用涂层解决方案的需求,增加了医疗保健支出,并对市场的扩张产生了重大影响。 例如,根据美国医疗保健协会的数据,2021年美国医疗保健支出将达到4.3万亿美元,增长2.7%,达到人均12,914美元。 这正在推动医用涂料市场的发展。 此外,美国国内生产总值的 18.3% 用于医疗保健。
医疗设备需要特定的性能特征,例如减少摩擦、提高耐磨性、增强生物相容性和提高耐用性。 喷涂可以根据这些要求进行定制,提供一种经济有效的方法来提高医疗器械的性能和功能,从而推动医疗涂料市场对喷涂的需求。
按地区划分,医用涂料市场分为北美、南美、欧洲、中东和非洲以及亚太地区。
印度医用涂料市场预计在预测期内将大幅增长。 这种增长是由于印度人口老龄化等多种因素造成的。 随着人口老龄化,对医疗设备和装置的需求也在增加,从而增加了对医用涂料的需求。 医用涂料在确保医疗器械的安全性和有效性方面发挥着重要作用。 提供保护层,防止污染、提高耐用性并提高生物相容性。 这对于印度的老龄化社会尤其重要,因为印度容易发生感染,需要长期住院。 例如,2021年,帝斯曼生物医学在印度推出了新型亲水涂层2.0,旨在提高血管介入治疗中使用的医疗器械的性能和安全性。
此外,癌症、糖尿病和心血管疾病等慢性疾病的流行正在推动印度医用涂料市场的增长。 这些疾病通常需要支架、导管和植入物等医疗设备,而这些设备在很大程度上依赖于医用涂层才能正常发挥作用。 印度慢性病患病率上升是由生活方式改变、城市化进程加快和人口老龄化等多种因素造成的。 全球疾病负担还估计,印度的糖尿病患病率将从1990年的26□□00万增加到2019年的7700万,并在2030年进一步增加到1.01亿。预测。 此外,2018年印度新增癌症患者116万,预计2040年将增至162万。
Medical equipment, implants, and gadgets must be coated with materials or coatings to enhance their functionality and safety. The prevalence of infections, the expansion of minimally invasive surgical techniques, and the strong demand for medical devices are all contributing reasons to the market's growth. Additionally, this market is anticipated to expand significantly due to the rising demand for customized and multifunctional coatings. Further, ongoing research and development offer new, creative coating options. In addition, product innovation and strategic actions by major market participants create numerous opportunities to expand into new application areas.
However, the factors that are anticipated to restrain the growth of this market are the rising prices of raw materials and the risk of coating failures. The use of hydrophilic and hydrophobic coated medical equipment carries a risk of coating failure, which is one of the main challenges for the growth of this market. In addition, other significant factors like the biocompatibility restrictions on some coating types, the lack of standardized practices, the possibility of coating failure, and the durability of the coating will also hamper the market growth.
The increasing rates of infections are associated with longer hospital stays. Common hospital-acquired infections are caused by medical equipment such as urine catheters, central lines, and mechanical ventilators. As they come into contact with the human body, they serve as a vehicle for the spread of hospital-acquired illnesses. Therefore, antimicrobial coatings on medical devices are becoming more popular due to the need to lower hospital-acquired infections. This is because it seems to be the most effective way to enhance infection control in a hospital environment without sacrificing patient care. With the rise in hospital-acquired infections, the usage of antimicrobial coatings is expanding. For instance, according to the U.S. Center for Disease Control and Prevention, more than 98,000 individuals die due to healthcare-associated infections, which affect about 1.7 million hospitalized patients every year. In addition, the percentage of infected patients within the ICU is as high as 51%, according to the Extended Prevalence of Infection in Intensive Care research.
Moreover, the prevalence of chronic diseases is driving the use of various medical procedures. This, in turn, is augmenting the demand for medical coating solutions and increasing healthcare expenditure, significantly influencing the market's expansion. For instance, as per the American Healthcare Association, healthcare spending in the U.S. rose by 2.7 percent in 2021 to reach USD 4.3 trillion, accounting for USD 12,914 per person. This aids in boosting the medical coating market. Additionally, 18.3% of the United States Gross Domestic Product was spent on health care.
Medical devices require specific performance characteristics, such as reduced friction, improved wear resistance, enhanced biocompatibility, and increased durability. Spray coatings can be tailored to meet these requirements, providing a cost-effective and efficient way to improve the performance and functionality of medical devices, which drives the demand for spray coatings in the medical coating market.
The medical coating market has been segmented by geography into North America, South America, Europe, Middle East and Africa, and Asia Pacific.
The Indian medical coating market is expected to grow significantly during the projected period. This growth can be attributed to various factors, such as the aging population in India. As the population ages, the demand for medical devices and equipment also increases, which drives the need for medical coatings. Medical coatings play a crucial role in ensuring the safety and effectiveness of medical devices. They provide a protective layer that prevents contamination, improves durability, and enhances biocompatibility. This is particularly important for the aging population in India, who are more susceptible to infections and require longer hospital stays. For instance, in 2021, DSM Biomedical launched its new Hydrophilic Coating 2.0 in India, designed to improve the performance and safety of medical devices used in vascular interventions.
Moreover, the prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases in India is driving the growth of the medical coating market. These conditions often require medical devices such as stents, catheters, and implants, which rely heavily on medical coatings to function properly. The rising prevalence of chronic diseases in India can be attributed to several factors, including changes in lifestyle, increased urbanization, and an aging population. In addition, the Global Burden of Disease estimates that the prevalence of diabetes in India has risen from 26 million in 1990 to 77 million in 2019, with projections indicating a further increase to 101 million by 2030. The study also estimates that there were 1.16 million new cancer cases in India in 2018, which is projected to increase to 1.62 million cases by 2040.